Release of new mRNA nanoparticles for prime & base editing

GEG Tech launches a series of collaborations with leading research institutions to enable high-precision gene therapy based on genome editing

.

press image4

GEG Tech announces the release of a new mRNA nanoparticle technology, designed to deliver novel prime and base editing systems. Leading research institutions in the field of genome editing, including the Broad Institute of MIT and Harvard, have initiated collaborations with GEG Tech to test the technology with their own systems. The objective is to shape the future of gene therapy, with a new generation of high-precision, high-efficacy and high-safety treatments.

To receive the link to PDF version of the press release, please enter your email address:


    We respect your privacy and personal data. By submitting your details and downloading our document you are accepting our Privacy Policy which can be found here.


     
     

    more on GEG Tech

    If you’d like to have more news about GEG Tech, visit our dedicated page.